• Open Access

Ability to cycle despite severe freezing of gait in atypical parkinsonism in Fahr's syndrome

Authors

  • Maria Stamelou MD,

    Corresponding author
    1. Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom
    2. Department of Neurology, Philipps University, Marburg, Germany
    • Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author
  • Maja Kojovic MD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author
  • Mark J. Edwards MD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author
  • Kailash P. Bhatia MD

    1. Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: M.J.E. receives royalties from the publication of the Oxford Specialist Handbook of Parkinson's Disease and Other Movement Disorders (Oxford University Press, 2008) and receives research support from a National Institute for Health Research (NIHR) grant, where he is the PI. He has received support for conference travel and accommodation from Teva Pharmaceuticals and UCB Pharmaceuticals. K.B. received funding for travel from GlaxoSmithKline, Orion Corporation, Ipsen, and Merz Pharmaceuticals, LLC, serves on the editorial boards of Movement Disorders and Therapeutic Advances in Neurological Disorders, receives royalties from the publication of the Oxford Specialist Handbook of Parkinson's Disease and Other Movement Disorders (Oxford University Press, 2008), received speaker honoraria from GlaxoSmithKline, Ipsen, Merz Pharmaceuticals, LLC, and Sun Pharmaceutical Industries Ltd., and received research support from Ipsen and the Halley Stewart Trust through Dystonia Society UK and the Wellcome Trust MRC strategic neurodegenerative disease initiative award (Ref. no.: WT089698). M.S. and M.K. have no disclosures.

    Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary